Mind-Body Program for Brain Tumor Couples
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a couple-based mind-body program can improve the quality of life for people with brain tumors and their partners. The program includes deep-breathing and meditation exercises, along with phone calls to support emotional and physical well-being. It is designed for patients who have recently started cancer treatment and have a partner willing to participate. Those experiencing sleep difficulties or feeling down due to a brain tumor diagnosis might find this trial beneficial. Participants must have internet access and be able to read and speak English. As an unphased trial, this study offers a unique opportunity to explore innovative support methods for enhancing well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mind-body intervention procedure is safe?
Research shows that mind-body programs, like the one in this study, are generally safe for people with brain tumors. Studies have found that these programs can help reduce stress and anxiety without major safety issues. Previous research reported no serious side effects. Participants often experienced a better quality of life, including improved sleep and mood. This suggests that the mind-body program is well-tolerated.12345
Why are researchers excited about this trial?
Researchers are excited about the Mind-Body Intervention for brain tumor patients and their partners because it offers a holistic approach that addresses both physical and emotional well-being. Unlike traditional treatments that focus solely on the physical aspects of brain tumors, this program integrates deep-breathing and meditation exercises, which can help manage stress and improve overall quality of life. By providing regular sessions and follow-up support through phone calls, this intervention promotes a supportive environment that can positively impact mood, relationships, and even work productivity. This comprehensive approach is what makes it stand out from conventional treatment options.
What evidence suggests that this mind-body program is effective for improving quality of life in brain tumor patients and their partners?
This trial will compare a mind-body intervention program with a waitlist control group for couples dealing with brain tumors. Studies have shown that mind-body programs, including meditation and deep-breathing exercises, can improve spiritual and emotional well-being. Early findings suggest they may also help with sleep problems and feelings of depression. One study found that these programs are feasible and may effectively enhance the overall quality of life for both patients and their partners. By focusing on relaxation and connection, these activities aim to support couples through their cancer journey.14567
Who Is on the Research Team?
Kathrin Milbury
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for couples where one partner has a high or low grade glioma, or a tumor that has spread to the brain. The patient must have started cancer treatment within the last month and be fairly active (KPS of 80+). Both partners need to speak English, consent to participate, and have internet access.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a couple-based mind-body program consisting of deep-breathing and meditation exercise sessions and weekly telephone calls for 6 weeks
Follow-up
Participants are monitored for quality of life outcomes and other measures after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mind-Body Intervention Procedure
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator